Shares of NeoGenomics tumbled after the oncology testing-services company said its chief executive, Chris Smith, will retire April 1. The stock fell 20%, to $14.91, in afternoon trading Friday. Shares ...

Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.

The top order and the spin department are areas of major concern as the selectors sit down to pick the Bangladesh squad for ...

Scorpion’s drug candidate inhibits a mutation that is a major driver of breast, gynaecological and head and neck cancers ...

Jasprit Bumrah suffered a back spasm during the India vs Australia fifth Test in Sydney and did not bowl in the second ...